A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
Adjei AA, Reid JM, Erlichman C, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Ruben S, Boemer SA, Atherton P, Ames MM, Kaufmann SH.
Adjei AA, et al. Among authors: ames mm.
Invest New Drugs. 2002 Aug;20(3):297-304. doi: 10.1023/a:1016237426846.
Invest New Drugs. 2002.
PMID: 12201492
Clinical Trial.